期刊
JOURNAL OF VIROLOGY
卷 74, 期 15, 页码 6893-6910出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.74.15.6893-6910.2000
关键词
-
类别
资金
- NIAID NIH HHS [R01 AI041420, R01 AI41420] Funding Source: Medline
- NIMHD NIH HHS [L60 MD003100] Funding Source: Medline
We have used coreceptor-targeted inhibitors to investigate which coreceptors are used by human immunodeficiency virus type I (HIV-1), simian immunodeficiency viruses (SIV), and human immunodeficiency virus type 2 (HIV-2) to enter peripheral blood mononuclear cells (PBMC). The inhibitors are TAK-779, which is specific for CCR5 and CCR2, aminooxypentane-RANTES, which blocks entry via CCR5 and CCR3, and AMD3100, which targets CXCR4. We found that for ail the HIV-1 isolates and all hut one of the HIV-2 isolates tested, the only relevant coreceptors were CCR5 and CXCR4. However, one HIV-2 isolate replicated in human PBMC even in the presence of TAK-779 and AMD3100, suggesting that it might use an undefined, alternative coreceptor that is expressed in the cells of some individuals. SIV(mac)239 and SIV(mac)251 (from macaques) were also able to use an alternative coreceptor to enter PBMC from some, but not all, human and macaque donors. The replication in human PBMC of SIVrcm (from a red-capped mangabey), a virus which uses CCR2 but not CCR5 for entry, was blocked by TAK-779, suggesting that CCR2 is indeed the paramount coreceptor for this virus in primary cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据